HCA Healthcare, Inc.
HCANYSEHealthcare● Active
$359.35
$-12.78(-3.43%)
Market Cap$79.7B
P/E Ratio—
52W High$556.52
52W Low$330
HCA Healthcare, Inc. (HCA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HCA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 24, 2026EPS Actual
$7.15
Est. $7.12 · +0.4%
Revenue
$19.11B
Est. $19.09B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 24, 2026
After Market Close
🔥 10-Quarter EPS Beat Streak
HCA reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 24, 2026 | $7.37 | — | — | — | $19.35B | — |
| — Q2 FY2026 | Apr 24, 2026 | $7.12 | $7.15 | +0.4% | $19.11B | $19.09B | +0.1% |
| ▲ Q1 FY2026 | Jan 27, 2026 | $7.46 | $8.01 | +7.4% | $19.51B | $19.68B | -0.9% |
| ▲ Q4 FY2025 | Oct 24, 2025 | $5.79 | $6.96 | +20.2% | $19.16B | $18.60B | +3.0% |
| ▲ Q3 FY2025 | Jul 25, 2025 | $6.29 | $6.84 | +8.7% | $18.61B | $18.50B | +0.6% |
| ▲ Q2 FY2025 | Apr 25, 2025 | $5.75 | $6.45 | +12.2% | $18.32B | $18.26B | +0.3% |
| ▲ Q1 FY2025 | Jan 24, 2025 | $6.13 | $6.22 | +1.5% | $18.29B | $18.23B | +0.3% |
| — Q4 FY2024 | Oct 25, 2024 | $4.99 | $5.03 | +0.8% | $17.49B | $17.54B | -0.3% |
Q3 FY2026
Jul 24, 2026
EPS Actual
—
EPS Est.
$7.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 24, 2026
EPS Actual
$7.15
EPS Est.
$7.12
EPS Surpr.
+0.4%
Revenue
$19.11B
Q1 FY2026
Jan 27, 2026Beat
EPS Actual
$8.01
EPS Est.
$7.46
EPS Surpr.
+7.4%
Revenue
$19.51B
Q4 FY2025
Oct 24, 2025Beat
EPS Actual
$6.96
EPS Est.
$5.79
EPS Surpr.
+20.2%
Revenue
$19.16B
Q3 FY2025
Jul 25, 2025Beat
EPS Actual
$6.84
EPS Est.
$6.29
EPS Surpr.
+8.7%
Revenue
$18.61B
Q2 FY2025
Apr 25, 2025Beat
EPS Actual
$6.45
EPS Est.
$5.75
EPS Surpr.
+12.2%
Revenue
$18.32B
Q1 FY2025
Jan 24, 2025Beat
EPS Actual
$6.22
EPS Est.
$6.13
EPS Surpr.
+1.5%
Revenue
$18.29B
Q4 FY2024
Oct 25, 2024
EPS Actual
$5.03
EPS Est.
$4.99
EPS Surpr.
+0.8%
Revenue
$17.49B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $9.91 | $10.21 | $10.42 | 7 |
| Q3 FY2028 | $8.15 | $8.41 | $8.58 | 12 |
| Q2 FY2028 | $8.33 | $8.59 | $8.76 | 7 |
| Q1 FY2028 | $8.29 | $8.55 | $8.72 | 7 |
| Q4 FY2027 | $9.16 | $9.44 | $9.64 | 6 |
| Q3 FY2027 | $7.74 | $7.98 | $8.14 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $21.9B | $22.4B | $22.7B | 6 |
| Q3 FY2028 | $21.3B | $21.8B | $22.2B | 6 |
| Q2 FY2028 | $20.7B | $21.2B | $21.5B | 6 |
| Q1 FY2028 | $20.7B | $21.2B | $21.5B | 6 |
| Q4 FY2027 | $20.7B | $21.2B | $21.5B | 7 |
| Q3 FY2027 | $20.2B | $20.7B | $21.0B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 24, 2026 | +0.4% | $474.03 | $432.46 | -8.77% |
| ▲ Q1 FY2026 | Jan 27, 2026 | +7.4% | $472.38 | $505.84 | +7.08% |
| ▲ Q4 FY2025 | Oct 24, 2025 | +20.2% | $440.16 | $447.04 | +1.56% |
| ▲ Q3 FY2025 | Jul 25, 2025 | +8.7% | $341.48 | $334.32 | -2.10% |
| ▲ Q2 FY2025 | Apr 25, 2025 | +12.2% | $341.41 | $327.92 | -3.95% |
| ▲ Q1 FY2025 | Jan 24, 2025 | +1.5% | $325.36 | $313.07 | -3.78% |
| ▲ Q4 FY2024 | Oct 25, 2024 | +0.8% | $398.90 | $363.55 | -8.86% |
| ▲ Q3 FY2024 | Jul 23, 2024 | +14.0% | $325.38 | $340.17 | +4.55% |
Q2 FY2026-8.77%
Report Date
Apr 24, 2026
EPS Beat/Miss
+0.4%
Price Before
$474.03
Price After
$432.46
Q1 FY2026+7.08%
Report Date
Jan 27, 2026
EPS Beat/Miss
+7.4%
Price Before
$472.38
Price After
$505.84
Q4 FY2025+1.56%
Report Date
Oct 24, 2025
EPS Beat/Miss
+20.2%
Price Before
$440.16
Price After
$447.04
Q3 FY2025-2.10%
Report Date
Jul 25, 2025
EPS Beat/Miss
+8.7%
Price Before
$341.48
Price After
$334.32
Q2 FY2025-3.95%
Report Date
Apr 25, 2025
EPS Beat/Miss
+12.2%
Price Before
$341.41
Price After
$327.92
Q1 FY2025-3.78%
Report Date
Jan 24, 2025
EPS Beat/Miss
+1.5%
Price Before
$325.36
Price After
$313.07
Q4 FY2024-8.86%
Report Date
Oct 25, 2024
EPS Beat/Miss
+0.8%
Price Before
$398.90
Price After
$363.55
Q3 FY2024+4.55%
Report Date
Jul 23, 2024
EPS Beat/Miss
+14.0%
Price Before
$325.38
Price After
$340.17
Avg Beat Reaction-1.78%
Beat Rate8 / 8 quarters
Largest Move-8.86% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HCA ends December
HCA Healthcare, Inc. (HCA) most recently reported earnings on April 24, 2026 for Q2 FY2026, posting EPS of $7.15 (in line with the analyst consensus of $7.12). HCA has beaten EPS estimates for 10 consecutive quarters. The next HCA earnings date is expected around September 1, 2026.
Each quarter, investors track HCA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HCA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HCA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HCA earnings · 4 questionsHCA Healthcare, Inc.'s next earnings report is expected around September 1, 2026. HCA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HCA historically reports after market close (AMC).
HCA earnings datewhen is HCA earningsHCA next earnings datewhen does HCA report earningsHCA earnings calendar
▸ Source: FMP · HCA Healthcare, Inc. SEC filings · US GAAP · HCA Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026